Expressions of phosphorylated AKT and phosphorylated EGFR in non-small cell lung cancer and their significance
Lihong Fan
Abstract
Lihong Fan
Abstract
Objective:To evaluate the expressions of phosphorylated epidermal growth factor receptor(p-EGFR) and its downstream molecule phosphorylated AKT(p-AKT) in non-small cell lung cancer(NSCLC)and their significance.Methods:The immunhistochemistry was used to detect the expressions of p-AKT and p-EGFR proteins in 95 cases of NSCLC tissues.The relationship between the p-AKT and p-EGFR and between their expression and prognosis were also evaluated.Results:The positive rate of p-EGFR was 57.89%(55/95) and was related with age,gender and histological type(P=0.008,P=0.003,P=0.009).The positivity of p-EGFR was higher in young group(33/46),female group(24/30),and adenocarcinoma group(35/52).The positive rate of p-AKT was 66.32%(63/95) and was related with differentiation,lymph node metastasis and tumor size(P=0.036,P=0.047,P=0.017,res-pectively).The positivity of p-AKT was higher in low differentiation group(20/23),lymph node metastasis group(29/37),and tumor diameter ≤3 cm group(36/46).Univariate analysis showed that the expressions of p-AKT and p-EGFR were not associated with prognosis(P=0.854,P=0.729).Multivariate analysis showed that neither p-AKT nor p-EGFR was correlated with the patients' survival time(P=0.497,P=0.731).The p-AKT was positively correlated to the p-EGFR(r=0.204,P=0.047).Conclusion:The expressions of p-AKT and p-EGFR had no impact on the prognosis of NSCLC.They can not serve as prognostic indicators for NSCLC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the expressions of phosphorylated epidermal growth factor receptor(p-EGFR) and its downstream molecule phosphorylated AKT(p-AKT) in non-small cell lung cancer(NSCLC)and their significance.Methods:The immunhistochemistry was used to detect the expressions of p-AKT and p-EGFR proteins in 95 cases of NSCLC tissues.The relationship between the p-AKT and p-EGFR and between their expression and prognosis were also evaluated.Results:The positive rate of p-EGFR was 57.89%(55/95) and was related with age,gender and histological type(P=0.008,P=0.003,P=0.009).The positivity of p-EGFR was higher in young group(33/46),female group(24/30),and adenocarcinoma group(35/52).The positive rate of p-AKT was 66.32%(63/95) and was related with differentiation,lymph node metastasis and tumor size(P=0.036,P=0.047,P=0.017,res-pectively).The positivity of p-AKT was higher in low differentiation group(20/23),lymph node metastasis group(29/37),and tumor diameter ≤3 cm group(36/46).Univariate analysis showed that the expressions of p-AKT and p-EGFR were not associated with prognosis(P=0.854,P=0.729).Multivariate analysis showed that neither p-AKT nor p-EGFR was correlated with the patients' survival time(P=0.497,P=0.731).The p-AKT was positively correlated to the p-EGFR(r=0.204,P=0.047).Conclusion:The expressions of p-AKT and p-EGFR had no impact on the prognosis of NSCLC.They can not serve as prognostic indicators for NSCLC.
Key concepts: Protein kinase B, Epidermal growth factor receptor, Lung cancer, Medicine, Adenocarcinoma, Internal medicine, Phosphorylation, Cancer